Eicosanoids are known to be involved in inflammation and insulin sensitivity72, suggesting dysregulation of PLA2s may increase insulin resistance and related metabolic disorders via disruption of eicosanoid signaling. The gene discussed is PLA2G2A; the disease is metabolic disease.